Keyword search (4,163 papers available)

"Joober R" Authored Publications:

Title Authors PubMed ID
1 The effects of intranasal oxytocin on the efficacy of psychotherapy for major depressive disorder: a pilot randomized controlled trial Ellenbogen MA; Cardoso C; Serravalle L; Vadaga K; Joober R; 38445382
PSYCHOLOGY
2 DNA methylation in people with Anorexia Nervosa: Epigenome-wide patterns in actively ill, long-term remitted, and healthy-eater women Steiger H; Booij L; Thaler L; St-Hilaire A; Israël M; Casey KF; Oliverio S; Crescenzi O; Lee V; Turecki G; Joober R; Szyf M; Breton É; 35703085
PSYCHOLOGY
3 Description, evaluation and scale-up potential of a model for rapid access to early intervention for psychosis. MacDonald K, Malla A, Joober R, Shah JL, Goldberg K, Abadi S, Doyle M, Iyer SN 29582562
CONCORDIA
4 Intranasal oxytocin and salivary cortisol concentrations during social rejection in university students. Linnen AM, Ellenbogen MA, Cardoso C, Joober R 22044077
CRDH
5 The acute effects of intranasal oxytocin on automatic and effortful attentional shifting to emotional faces. Ellenbogen MA, Linnen AM, Grumet R, Cardoso C, Joober R 22092248
PSYCHOLOGY
6 Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study. Cardoso C, Ellenbogen MA, Orlando MA, Bacon SL, Joober R 22889586
PSYCHOLOGY
7 Intranasal oxytocin impedes the ability to ignore task-irrelevant facial expressions of sadness in students with depressive symptoms. Ellenbogen MA, Linnen AM, Cardoso C, Joober R 22902063
PSYCHOLOGY
8 Intranasal oxytocin attenuates the human acoustic startle response independent of emotional modulation. Ellenbogen MA, Linnen AM, Cardoso C, Joober R 25082371
CRDH
9 Cognitive capacity similarly predicts insight into symptoms in first- and multiple-episode psychosis. Sauvé G, Kline RB, Shah JL, Joober R, Malla A, Brodeur MB, Lepage M 30514643
PSYCHOLOGY
10 A longitudinal, epigenome-wide study of DNA methylation in anorexia nervosa: results in actively ill, partially weight-restored, long-term remitted and non-eating-disordered women Steiger H, Booij L, Kahan `, McGregor K, Thaler L, Fletcher E, Labbe A, Joober R, Israël M, Szyf M, Agellon LB, Gauvin L, St-Hilaire A, Rossi E 30693739
PSYCHOLOGY

 

Title:Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study.
Authors:Cardoso CEllenbogen MAOrlando MABacon SLJoober R
Link:https://www.ncbi.nlm.nih.gov/pubmed/22889586?dopt=Abstract
Publication:
Keywords:
PMID:22889586 Category:Psychoneuroendocrinology Date Added:2019-06-07
Dept Affiliation: PSYCHOLOGY
1 Centre for Research in Human Development, Department of Psychology, Concordia University, Montréal, QC, Canada.

Description:

Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study.

Psychoneuroendocrinology. 2013 Mar;38(3):399-407

Authors: Cardoso C, Ellenbogen MA, Orlando MA, Bacon SL, Joober R

Abstract

INTRODUCTION: Intranasal oxytocin attenuates cortisol levels during social stress inductions. However, no research to date has documented the dose-response relation between intranasal oxytocin administration and cortisol, and researchers examining intranasal oxytocin have not examined the cortisol response to physical stress. We therefore examined the effects of 24IU and 48IU of intranasal oxytocin on the cortisol response to vigorous exercise.

METHOD: Seventeen males participated in a randomized, placebo-controlled, double-blind, and within-subject experiment. Participants engaged in vigorous exercise for 60min following the administration of placebo or intranasal oxytocin on three occasions. Saliva samples and mood ratings were collected at eight intervals across each session.

RESULTS: Salivary cortisol concentrations changed over time, peaking after 60min of exercise (quadratic: F(1,16)=7.349, p=.015, partial ?(2)=.32). The 24IU dose of oxytocin attenuated cortisol levels relative to placebo (F(1,16)=4.496, p=.05, partial ?(2)=.22) and the 48IU dose, although the latter fell just short of statistical significance (F(1,16)=3.054, p=.10, partial ?(2)=.16). There was no difference in the cortisol response to exercise in participants who were administered 48IU of intranasal oxytocin relative to placebo. Intranasal oxytocin had no effect on mood.

CONCLUSION: This is the first study to demonstrate that the effect of intranasal oxytocin on salivary cortisol is dose-dependent, and that intranasal oxytocin attenuates cortisol levels in response to physical stress. Future research using exogenous oxytocin will need to consider the possibility of dose-response relations.

PMID: 22889586 [PubMed - indexed for MEDLINE]





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University